AI assistant
Sending…
HALLIBURTON CO — Director's Dealing 2025
Jan 6, 2025
30269_dirs_2025-01-06_3c554d73-e7c9-4624-847c-e62f349ac49e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: HALLIBURTON CO (HAL)
CIK: 0000045012
Period of Report: 2025-01-02
Reporting Person: Carre Eric (EVP & Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-01-02 | Common Stock | A | 37180 | $27.73 | Acquired | 272782.377 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Option to Buy Common Stock | $39.49 | 2025-01-02 | Common Stock (24750) | 0 | Direct |
| Option to Buy Common Stock | $31.44 | 2028-12-05 | Common Stock (50100) | 50100 | Direct |
| Option to Buy Common Stock | $43.38 | 2027-12-06 | Common Stock (34425) | 34425 | Direct |
| Option to Buy Common Stock | $53.54 | 2026-12-07 | Common Stock (30100) | 30100 | Direct |
| Option to Buy Common Stock | $34.48 | 2026-01-04 | Common Stock (9534) | 9534 | Direct |
Footnotes
F1: Shares awarded pursuant to the Halliburton Company Stock and Incentive Plan. Said Plan provides for the surrender of common stock to the Issuer to satisfy withholding tax obligations.
F2: The closing price of Halliburton Company's Common Stock on the New York Stock Exchange on the January 2, 2025 grant date was $27.73.
F3: Includes 907.710 shares of stock accumulated through dividend reinvestment as of December 31, 2024.
F4: Stock option expired January 2, 2025.
More from HALLIBURTON CO
Regulatory Filings
2026
May 29
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 20
Major Shareholding Notification
2026
Apr 30
Interim / Quarterly Report
2026
Apr 24
Regulatory Filings
2026
Apr 21
Major Shareholding Notification
2026
Apr 6
Proxy Solicitation & Information Statement
2026
Mar 31
Proxy Solicitation & Information Statement
2026
Mar 31
Director's Dealing
2026
Mar 30